Bionano Genomics (BNGO) Receivables (2017 - 2025)
Bionano Genomics (BNGO) has disclosed Receivables for 9 consecutive years, with $5.2 million as the latest value for Q4 2025.
- Quarterly Receivables rose 9.17% to $5.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, up 9.17% year-over-year, with the annual reading at $5.2 million for FY2025, 9.17% up from the prior year.
- Receivables hit $5.2 million in Q4 2025 for Bionano Genomics, up from $4.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $10.1 million in Q4 2023 to a low of $2.0 million in Q1 2021.
- Historically, Receivables has averaged $5.8 million across 5 years, with a median of $5.5 million in 2022.
- Biggest five-year swings in Receivables: plummeted 64.61% in 2021 and later surged 176.81% in 2022.
- Year by year, Receivables stood at $6.0 million in 2021, then grew by 24.7% to $7.5 million in 2022, then soared by 35.33% to $10.1 million in 2023, then plummeted by 52.94% to $4.8 million in 2024, then increased by 9.17% to $5.2 million in 2025.
- Business Quant data shows Receivables for BNGO at $5.2 million in Q4 2025, $4.5 million in Q3 2025, and $3.5 million in Q2 2025.